[Mode of action of blood glucose lowering sulfonamides. Other extrapancreatic effects].
D000818:Animals; D001786:Blood Glucose / Q000032:analysis*; D002247:Carbon Isotopes; D002415:Cats; D004285:Dogs; D004357:Drug Synergism; D005947:Glucose / Q000378:metabolism / Q000494:pharmacology; D006498:Hepatectomy; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007263:Infusions, Parenteral; D007328:Insulin / Q000097:blood / Q000494:pharmacology; D007515:Islets of Langerhans / Q000502:physiology; D008099:Liver / Q000502:physiology; D008970:Molecular Weight; D010179:Pancreas / Q000502:physiology; D010180:Pancreatectomy; D011817:Rabbits; D051381:Rats; D013449:Sulfonamides / Q000494:pharmacology*; D014044:Tolbutamide / Q000494:pharmacology
D001786:Blood Glucose; D002247:Carbon Isotopes; D007004:Hypoglycemic Agents; D007328:Insulin; D013449:Sulfonamides; D014044:Tolbutamide; D005947:Glucose